Amplitude Healthcare Acquisition Corporation
AMHC News Today: Stay Updated with the Latest Amplitude Healthcare Acquisition Corporation News in Real Time
Find AMHC news now at Meyka AI. Stay informed with the latest Amplitude Healthcare Acquisition Corporation stocks updates, including price news, market analysis, and expert insights.

Jefferies Maintains Buy on AAR Corp. (AIR) March 24, 2026
Jefferies maintains Buy on AAR Corp. AIR analyst rating updated March 24, 2026; investor implications and market context

NUMI.TO Numinus Wellness (TSX) C$0.05 close Apr 08 2026: earnings to watch
NUMI.TO stock closes C$0.05 ahead of Apr 9 earnings; Meyka AI forecast shows potential upside vs current price

April 8: Lawsuit Challenges DOJ Memo on Presidential Records, Transparency
April 8 lawsuit targets a DOJ OLC memo on the Presidential Records Act, reshaping transparency, separation of powers, and investor risks across U.S. regulated sectors.

AYA.AX Artrya Limited ASX up 25.40% pre-market 09 Apr 2026: AI imaging momentum
AYA.AX stock pre-market jump to A$3.90 on 09 Apr 2026; AI imaging traction and Meyka AI forecasts listed

CGNX stock +4.04% to $53.78 NASDAQ 08 Apr 2026: AI demand supports Cognex
CGNX stock update: price $53.78, P/E 79.09, Meyka AI forecast $33.96, AI-driven machine vision trends

Morgan Stanley Maintains Boyd Gaming Corporation (BYD) Rating April 2026
Morgan Stanley maintained Boyd Gaming; implications for BYD analyst rating and $87 price target

April 9: Japan Weighs Land Curbs as Kasasa Island Sale Stokes Security Fears
Japan considers tighter land rules after the Kasasa Island land purchase near the Iwakuni base. Nationality-neutral curbs are on the table, with potential effects on cross-border real estate flows and

Daiwa House Stock Today: Exits Elder Care via ALSOK Deal — April 9
Daiwa House exits elder care, selling two subsidiaries to ALSOK with closing targeted for June 1. We explain what the deal means, why Daiwa House is refocusing its portfolio, and what investors in JP,

Citigroup starts coverage of Summit Therapeutics Inc (SMMT), Apr 08 2026, Buy
Citigroup begins coverage Apr 08 2026; SMMT analyst rating set to Buy by Citigroup